Life SciencesImmunologyPharmacologyCellular ImmunologyHypersensitivityImmunoregulationCell-mediated ImmunityEffector T Cell FunctionImmunosuppressionImmunosuppressive AgentsImmunosuppressive TherapyT Cell BiologyAntibody Production ImpairmentDrug-induced ImmunosuppressionLymphocyte Proliferation InhibitionT Cell-mediated Immune ResponseT-cell Immune ResponsesT-cell Mediated Immune ResponseT-cell Mediated ImmunityT-cell Mediated Responses
Studies involving the combined use of phytohaemagglutinin (PHA) and cyclophosphamide (CY) indicate that both agents can act together to produce immunological unresponsiveness: following injection of PHA into mice, splenic DNA synthetic responses [14C]thymidine incorporation) and haemolysin plaque formation against sheep red blood cells were determined in daily intervals. Both immunosuppression and DNA synthetic activity were maximally developed 5 days after treatment with PHA. Administration of CY at this time resulted in immunological unresponsiveness lasting for about 18 days. Antibody production could be completely restored with antigen-activated T cells (but not with B cells), thus indicating a selective inhibition of T-cell 'helper function' in mice treated with PHA and CY. This observation is consistent with the general assumption that cells involved in the response to PHA are predominantly T cells. Apparently, these cells are highly sensitive to an inactivation by CY after stimulation with PHA.
22
Plaque Formation in Agar by Single Antibody-Producing Cells
N. K. Jerne, Albert A. Nordin · Science · 1963 · 2.4K citations
JNCI Journal of the National Cancer Institute · 1966 · 528 citations
Medicine, Hematology, Oncology +10
Selective depletion of lymphoid tissue by cyclophosphamide.
J.L. Turk, L W Poulter · PubMed · 1972 · 359 citations